01
Telomere Biology
Investigated in cell-culture models of telomere maintenance and replicative ageing.
For research use only — not for human consumption

Endocrine Research
In stockCJC-1295 with DAC is a modified GHRH analog studied for extended receptor interaction and endocrine signaling pathway analysis [1,2] .
Professional pricing
Sign in or create a research account to see prices and add this material to your order. Access unlocks as soon as you create your account.
Sign in for pricingSpecifications
Lot & handling
Molecular
Analytics
When a lot certificate is on file we report identity, purity, and appearance. We publish analytical data only — never dosing information or outcome claims.
01
Chromatographic purity against a qualified reference standard.
02
Identity by observed versus theoretical molecular mass.
03
Residual moisture in lyophilized material.
04
Contaminant screening on raw material and finished lots.

Research background
Summary of the published literature this reference material is used in.
01
Investigated in cell-culture models of telomere maintenance and replicative ageing.
02
Studied for reported effects on transcriptional regulation in experimental systems.
03
Referenced in literature examining cellular senescence markers in vitro.
The Drug Affinity Complex (DAC) extends peptide persistence, allowing researchers to examine prolonged signaling effects [1].
Studies explore extended GHRH receptor activation and downstream endocrine pathway behavior [2].
CJC-1295 with DAC is often compared with non-DAC variants to evaluate signaling duration and pathway kinetics [1].
Key Specs
Referenced Citations
Mandatory research disclaimer
All materials on this site are sold as laboratory reagents for research use only. They are not drugs, foods, cosmetics, dietary supplements, or medical devices, and are not for human or veterinary use of any kind.
Senna Research makes no claims of safety or efficacy and provides no usage, dosing, or preparation guidance; we publish analytical data only.
These materials have not been evaluated or approved by the U.S. Food and Drug Administration for any use.